Northwestern Connection

A commercialization destination for Northwestern innovators

The science aPolyera and Aurasense was developed at Northwestern University in Evanston and Chicago.  Northwestern companies bring to the park technology solutions such as Spherical Nucleic Acid (SNA™) constructs, nanotechnology, and solution-processable functional materials.   

Other companies leverage the Northwestern Connection through recruitment of scientists and expert continuing education programs.  According to U.S News and World Report, Northwestern has the #2 program in materials, #3 program in manufacturing, and the top marketing program in the U.S.

Northwestern innovation support

The Innovation and New Ventures Office (INVO) inspires and nurtures a culture of innovation, bridging Northwestern research with its practical use for public benefit.  INVO coordinates with entrepreneurial and innovation initiatives across all schools within Northwestern. The goal is to drive the value and impact of the invention by facilitating alliances, to further technology validation and possibly to increase funding.

The Farley Center for Entrepreneurship and Innovation (FCEI) helps evolve engineering beyond the application of the sciences to the creation of businesses that capitalize on innovations.

The Nanoscale Science and Engineering Center (NSEC) for Integrated Nanopatterning and Detection Technologies is driven by a vision to develop innovative biological and chemical detection systems capable of revolutionizing a variety of fields. Genuine medical benefits are now emerging as direct products of the center research, including detection techniques for markers associated with diseases such as Alzheimer's disease and prostate cancer.

International Institute for Nanotechnology (IIN) is a global hub of and currently represents and unites over $600 million in nanotechnology research, educational programs, and supporting infrastructure. Collaborative partnerships exist in 23 countries, many with faculty and student exchange programs. Over 900 patents have resulted from IIN research; 21 companies have been successfully launched based on IIN technologies; and over 200 products and systems have been commercialized. Extensive capabilities are available to enable cutting edge research and the IIN has invested $12 million in state-of-the-art instrumentation.

Center for Innovation in Global Health Technologies (CIGHT) recognizes the multidimensional complexity of the global healthcare challenge.  Working in alliance with corporate, not-for-profit, and education partners, CIGHT seeks not merely to develop, but bring to market comprehensive, context-appropriate healthcare solutions that integrate seamlessly with the lives of patients and medical practitioners in the developing world.